woensdag 13 juli 2022

#Valentijn RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition - Science

RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition  Science

via https://www.science.org/doi/10.1126/sciadv.abn1382
op

Geen opmerkingen:

Een reactie posten